Mitchell PL - Search Results

1

Reducing Artifactual EGFR T790M Mutations in DNA from Formalin-Fixed Paraffin-Embedded Tissue by Use of Thymine-DNA Glycosylase.

Do H, Molania R, Mitchell PL, Vaiskunaite R, Murdoch JD, Dobrovic A. Do H, et al. Among authors: mitchell pl. Clin Chem. 2017 Sep;63(9):1506-1514. doi: 10.1373/clinchem.2017.271932. Epub 2017 Jul 18. Clin Chem. 2017. PMID: 28720682

2

High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies.

Do H, Krypuy M, Mitchell PL, Fox SB, Dobrovic A. Do H, et al. Among authors: mitchell pl. BMC Cancer. 2008 May 21;8:142. doi: 10.1186/1471-2407-8-142. BMC Cancer. 2008. PMID: 18495026 Free PMC article.

3

Temporal changes of EGFR mutations and T790M levels in tumour and plasma DNA following AZD9291 treatment.

Chia PL, Do H, Morey A, Mitchell P, Dobrovic A, John T. Chia PL, et al. Among authors: mitchell p. Lung Cancer. 2016 Aug;98:29-32. doi: 10.1016/j.lungcan.2016.05.003. Epub 2016 May 11. Lung Cancer. 2016. PMID: 27393503

4

A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma.

Do H, Wong NC, Murone C, John T, Solomon B, Mitchell PL, Dobrovic A. Do H, et al. Among authors: mitchell pl. Sci Rep. 2014 Feb 26;4:4186. doi: 10.1038/srep04186. Sci Rep. 2014. PMID: 24569633 Free PMC article.

5

Digital PCR of Genomic Rearrangements for Monitoring Circulating Tumour DNA.

Do H, Cameron D, Molania R, Thapa B, Rivalland G, Mitchell PL, Murone C, John T, Papenfuss A, Dobrovic A. Do H, et al. Among authors: mitchell pl. Adv Exp Med Biol. 2016;924:139-146. doi: 10.1007/978-3-319-42044-8_27. Adv Exp Med Biol. 2016. PMID: 27753035

6

Combination Osimertinib and Gefitinib in C797S and T790M EGFR-Mutated Non-Small Cell Lung Cancer.

Arulananda S, Do H, Musafer A, Mitchell P, Dobrovic A, John T. Arulananda S, et al. J Thorac Oncol. 2017 Nov;12(11):1728-1732. doi: 10.1016/j.jtho.2017.08.006. Epub 2017 Aug 24. J Thorac Oncol. 2017. PMID: 28843359 Free article.

7

De novo activating epidermal growth factor mutations (EGFR) in small-cell lung cancer.

Thai A, Chia PL, Russell PA, Do H, Dobrovic A, Mitchell P, John T. Thai A, et al. Among authors: mitchell p. Intern Med J. 2017 Sep;47(9):1071-1074. doi: 10.1111/imj.13531. Intern Med J. 2017. PMID: 28891180

8

Standard dose osimertinib for erlotinib refractory T790M-negative EGFR-mutant non-small cell lung cancer with leptomeningeal disease.

Arulananda S, Do H, Rivalland G, Loh Z, Musafer A, Lau E, Mitchell P, Dobrovic A, John T. Arulananda S, et al. J Thorac Dis. 2019 May;11(5):1756-1764. doi: 10.21037/jtd.2019.05.41. J Thorac Dis. 2019. PMID: 31285867 Free PMC article.

9

Detection of the transforming AKT1 mutation E17K in non-small cell lung cancer by high resolution melting.

Do H, Solomon B, Mitchell PL, Fox SB, Dobrovic A. Do H, et al. Among authors: mitchell pl. BMC Res Notes. 2008 May 16;1:14. doi: 10.1186/1756-0500-1-14. BMC Res Notes. 2008. PMID: 18611285 Free PMC article.

10

Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors.

Chia PL, Mitchell P, Dobrovic A, John T. Chia PL, et al. Among authors: mitchell p. Clin Epidemiol. 2014 Nov 20;6:423-32. doi: 10.2147/CLEP.S69718. eCollection 2014. Clin Epidemiol. 2014. PMID: 25429239 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters